Pamela Aranda Lopez

649 total citations
15 papers, 131 citations indexed

About

Pamela Aranda Lopez is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Pamela Aranda Lopez has authored 15 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Pamela Aranda Lopez's work include Inflammation biomarkers and pathways (4 papers), Antifungal resistance and susceptibility (4 papers) and Immunotherapy and Immune Responses (4 papers). Pamela Aranda Lopez is often cited by papers focused on Inflammation biomarkers and pathways (4 papers), Antifungal resistance and susceptibility (4 papers) and Immunotherapy and Immune Responses (4 papers). Pamela Aranda Lopez collaborates with scholars based in Germany, Spain and Japan. Pamela Aranda Lopez's co-authors include Markus P. Radsak, Hansjörg Schild, Matthias Theobald, Daniel Teschner, Hans Christian Probst, Peter Langguth, H Beckert, Georg Heß, Markus Bosmann and Wolfram Ruf and has published in prestigious journals such as Blood, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Pamela Aranda Lopez

14 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Aranda Lopez Germany 8 94 27 25 20 18 15 131
Prashant V. Shinde Germany 8 64 0.7× 36 1.3× 55 2.2× 30 1.5× 19 1.1× 11 185
Seraina Prader Switzerland 6 85 0.9× 30 1.1× 20 0.8× 22 1.1× 21 1.2× 14 134
Shirly Frizinsky Israel 6 84 0.9× 53 2.0× 23 0.9× 38 1.9× 12 0.7× 13 191
Luis Murguía-Favela Canada 8 98 1.0× 9 0.3× 46 1.8× 24 1.2× 11 0.6× 22 182
Vesa Lindström Finland 8 41 0.4× 27 1.0× 39 1.6× 12 0.6× 23 1.3× 13 117
Adi Ovadia Israel 8 98 1.0× 19 0.7× 16 0.6× 22 1.1× 14 0.8× 18 158
Tom Le Voyer France 6 52 0.6× 26 1.0× 52 2.1× 12 0.6× 10 0.6× 10 114
Toshinori Moriguchi Japan 6 45 0.5× 25 0.9× 16 0.6× 24 1.2× 21 1.2× 7 109
Maja Klaudel‐Dreszler Poland 7 66 0.7× 13 0.5× 23 0.9× 14 0.7× 13 0.7× 24 123
Caridad Martinez United States 7 99 1.1× 23 0.9× 32 1.3× 8 0.4× 31 1.7× 15 150

Countries citing papers authored by Pamela Aranda Lopez

Since Specialization
Citations

This map shows the geographic impact of Pamela Aranda Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Aranda Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Aranda Lopez more than expected).

Fields of papers citing papers by Pamela Aranda Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Aranda Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Aranda Lopez. The network helps show where Pamela Aranda Lopez may publish in the future.

Co-authorship network of co-authors of Pamela Aranda Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Aranda Lopez. A scholar is included among the top collaborators of Pamela Aranda Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Aranda Lopez. Pamela Aranda Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lopez, Pamela Aranda, Peter Langguth, Hideo Yagita∥, et al.. (2019). Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice. European Journal of Immunology. 49(11). 2083–2094. 9 indexed citations
2.
Lopez, Pamela Aranda, Joachim Maxeiner, Markus Bosmann, et al.. (2019). Neutrophil extracellular traps impair fungal clearance in a mouse model of invasive pulmonary aspergillosis. Immunobiology. 225(1). 151867–151867. 29 indexed citations
3.
Lopez, Pamela Aranda, H Beckert, Matthias Theobald, et al.. (2019). Antifungal Drugs Influence Neutrophil Effector Functions. Antimicrobial Agents and Chemotherapy. 63(6). 9 indexed citations
4.
Lopez, Pamela Aranda, et al.. (2018). Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses. Scientific Reports. 8(1). 5558–5558. 20 indexed citations
5.
Lopez, Pamela Aranda, et al.. (2017). Idelalisib Impairs TREM-1 Mediated Neutrophil Inflammatory Responses. Blood. 130. 3569–3569.
6.
Lopez, Pamela Aranda, et al.. (2017). 9-Phenanthrol enhances the generation of an CD8 + T cell response following transcutaneous immunization with imiquimod in mice. Journal of Dermatological Science. 87(3). 260–267. 6 indexed citations
7.
Lopez, Pamela Aranda, Hans Christian Probst, Esther von Stebut, et al.. (2017). Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection. Journal of Dermatological Science. 87(3). 252–259. 20 indexed citations
8.
Lopez, Pamela Aranda, et al.. (2017). Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization. Journal of Dermatological Science. 87(3). 300–306. 11 indexed citations
9.
Reuter, Sebastian, Pamela Aranda Lopez, I. Scharrer, et al.. (2017). ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis. Scientific Reports. 7(1). 7184–7184. 7 indexed citations
10.
Lopez, Pamela Aranda, Jörn F. Dopheide, Frank P. Schmidt, et al.. (2016). Phenotypic and functional characterization of neutrophils and monocytes from patients with myelodysplastic syndrome by flow cytometry. Cellular Immunology. 308. 19–26. 9 indexed citations
11.
Lopez, Pamela Aranda, Alexander Desuki, Oliver Kriege, et al.. (2016). Ibrutinib Abrogates TREM-1 Mediated Neutrophil Activation. Blood. 128(22). 3691–3691. 1 indexed citations
12.
Lopez, Pamela Aranda, Alexander Desuki, Oliver Kriege, et al.. (2016). Idelalisib Impairs TREM-1 and TLR Mediated Neutrophil Activation. Blood. 128(22). 2510–2510. 1 indexed citations
13.
14.
Soler, L., Juan Carlos Rodrı́guez, Sylvia Belda Hofheinz, et al.. (2010). Generation of Mutants inCandida albicanswith Reduced Susceptibility to Caspofungin: Influence on Other Antifungal Products. Journal of Chemotherapy. 22(4). 283–284. 1 indexed citations
15.
Lopez, Pamela Aranda, Donald G. Morris, P. R. Galbraith, David Lillicrap, & Hugh F. Pross. (1993). Lymphoproliferative disease of 'lak cell' precursor large granular lymphocytes in association with celiac disease. American Journal of Hematology. 43(2). 116–122. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prashant V. Shinde Breakdown of academic impact, for papers by Seraina Prader Breakdown of academic impact, for papers by Shirly Frizinsky Breakdown of academic impact, for papers by Luis Murguía-Favela Breakdown of academic impact, for papers by Vesa Lindström Breakdown of academic impact, for papers by Adi Ovadia Breakdown of academic impact, for papers by Tom Le Voyer Breakdown of academic impact, for papers by Toshinori Moriguchi Breakdown of academic impact, for papers by Maja Klaudel‐Dreszler Breakdown of academic impact, for papers by Caridad Martinez
Rankless by CCL
2026